Drug Shortage Report for NAPROSYN
Report ID | 52317 |
Drug Identification Number | 02162423 |
Brand name | NAPROSYN |
Common or Proper name | naproxen |
Company Name | ATNAHS PHARMA UK LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | NAPROXEN |
Strength(s) | 500MG |
Dosage form(s) | TABLET (ENTERIC-COATED) |
Route of administration | ORAL |
Packaging size | Bottles of 100 tablets |
ATC code | M01AE |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2018-06-13 |
Estimated end date | 2018-09-21 |
Actual end date | 2018-09-20 |
Shortage status | Resolved |
Updated date | 2018-09-21 |
Company comments | For more information, please contact Methapharm Inc. at 1-800-287-7686, sales@methapharm.com or by fax at 1-519-751-9149. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | SOVEREIGN HOUSE, MILES GRAY ROAD BASILDON, ESSEX GREAT BRITAIN SS14 3FR |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-06-13 | English | Compare |
v2 | 2018-06-13 | French | Compare |
v3 | 2018-06-14 | English | Compare |
v4 | 2018-08-24 | English | Compare |
v5 | 2018-08-24 | French | Compare |
v6 | 2018-09-20 | English | Compare |
v7 | 2018-09-20 | French | Compare |
v8 | 2018-09-21 | English | Compare |
Showing 1 to 8 of 8